Circio invited to present circVec circular RNA technology at upcoming international RNA therapeutics conferences
Oslo, Norway 26 June 2024 – Circio Holding ASA (OSE: CRNA), a biotechnology company developing next generation circular RNA vector technology for gene therapy, today announces that CEO Dr. Erik Digman Wiklund and CSO Dr. Victor Levitsky have been invited to speak at two upcoming biopharma industry RNA conferences in Frankfurt, Germany, and San Diego, USA.
The European mRNA conference 2024
Title: Is circular RNA surpassing mRNA as the RNA format for the future?
Time & place: 26 June 2024, 11:00 CEST, Frankfurt, Germany
Presenter: Dr. Victor Levitsky, CSO
Title: Deploying circular RNA expression to boost gene therapy – AAV and beyond
Time & place: 4 September 2024, 15:05 PST, San Diego, USA
Presenter: Dr. Erik Digman Wiklund, CEO
These invitations to present at important RNA industry conferences place Circio along other leading RNA companies, such as Moderna, Biontech and oRNA Therapeutics. The presentations will provide an important forum to highlight the advantages and potential of circular RNA and reinforce Circio´s position as discoverers and leaders in this rapidly emerging field.
The presentations will be made available on Circio´s webpage on the respective dates.
